This will be Phase 1 clinical trials, ie they're mostly about side effects (and potentially dosage): ie they'll mostly check whether this will kill you / which dosage van be considered mostly safe. But at later trial stages, this will be one method to do this. Another and mich simpler one: you check whether the vaccinated people develop the antibodies you're looking for.
